Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason W Chien

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge studyJohn P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
Journal of the National Cancer Institute|August 17, 2010
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trialRowan T Chlebowski, Garnet L Anderson, JoAnn E Manson, et al.
Lancet (London, England)|September 22, 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialRowan T Chlebowski, Ann G Schwartz, Heather Wakelee, et al.
The Journal of Infection|August 25, 2024
The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19Robert L Gottlieb, Meredith Clement, Paul Cook, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2015
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell TransplantationKirsten M Williams, Guang-Shing Cheng, Iskra Pusic, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2017
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary FibrosisSlavé Petrovski, Jamie L Todd, Michael T Durheim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
JAMA|August 9, 2017
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical TrialAnne Bergeron, Sylvie Chevret, Angela Granata, et al.
Annals of Internal Medicine|May 8, 2013
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialGanesh Raghu, Juergen Behr, Kevin K Brown, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge studyJohn P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
Journal of the National Cancer Institute|August 17, 2010
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trialRowan T Chlebowski, Garnet L Anderson, JoAnn E Manson, et al.
Lancet (London, England)|September 22, 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialRowan T Chlebowski, Ann G Schwartz, Heather Wakelee, et al.
The Journal of Infection|August 25, 2024
The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19Robert L Gottlieb, Meredith Clement, Paul Cook, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2015
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell TransplantationKirsten M Williams, Guang-Shing Cheng, Iskra Pusic, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2017
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary FibrosisSlavé Petrovski, Jamie L Todd, Michael T Durheim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
JAMA|August 9, 2017
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical TrialAnne Bergeron, Sylvie Chevret, Angela Granata, et al.
Annals of Internal Medicine|May 8, 2013
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialGanesh Raghu, Juergen Behr, Kevin K Brown, et al.
Pageof 8